OBARIS
LIVE

Serial Number

79398667

Owner

OBaris AG

Attorney

Cheryl L. Foytlin

Filing Date

Apr 22, 2024

Add to watchlist:

No watchlists yet
View on USPTO

OBARIS Trademark

Serial Number: 79398667

OBARIS is a trademark filed by OBaris AG on April 22, 2024. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 35 (Advertising & Business). The application is currently pending registration.

Owner Contact Info

OBaris AG (2 trademarks)

Wagistrasse 18

Entity Type: 99

Trademark Details

Filing Date

April 22, 2024

Registration Date

Not Registered

Goods & Services

Advertising services; business management; business organization consulting; business administration; providing office functions.

Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; veterinary preparations for companion and livestock animals for the treatment of metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, respiratory, gastrointestinal, oncological, hepatological, ophthalmic, dermatological, neurological, and immune system-related conditions; sanitary preparations for medical purposes; dietetic foods adapted for medical and veterinary purposes; food for babies; dietary supplements for humans and animals; medical plasters, medical dressings; material for dental fillings and dental impressions; disinfectants; preparations for destroying vermin; fungicides; herbicides.

Scientific and technological services and research and design in the field of pharmaceuticals, medical devices, and biopharmaceuticals; industrial analysis consultation; industrial research in the field of pharmaceuticals, medical devices, and biopharmaceuticals; industrial design services; quality control of services; authentication of data in the field of pharmaceuticals, medical devices, and biopharmaceuticals.

Filing History

NOTIFICATION OF NON-FINAL ACTION E-MAILED
Feb 10, 2026 GNRN
NON-FINAL ACTION E-MAILED
Feb 10, 2026 GNRT
NON-FINAL ACTION WRITTEN
Feb 10, 2026 CNRT
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Dec 11, 2025 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Nov 26, 2025 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Nov 26, 2025 OPNR
NEW REPRESENTATIVE AT IB RECEIVED
Oct 9, 2025 NREP
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sep 12, 2025 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sep 12, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sep 12, 2025 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Sep 12, 2025 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Sep 12, 2025 COAR
REFUSAL PROCESSED BY IB
Aug 8, 2025 RFNP
NON-FINAL ACTION WRITTEN
Jul 14, 2025 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
May 12, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 12, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 12, 2025 TROA
REFUSAL PROCESSED BY IB
Nov 30, 2024 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Nov 14, 2024 RFCS
REFUSAL PROCESSED BY MPU
Nov 14, 2024 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Nov 8, 2024 RFCR
NON-FINAL ACTION WRITTEN
Nov 7, 2024 CNRT
ASSIGNED TO EXAMINER
Nov 4, 2024 DOCK
APPLICATION FILING RECEIPT MAILED
Jul 3, 2024 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 3, 2024 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jun 27, 2024 REPR